We have previously demonstrated that intracoronary infusion of the endothelium-dependent vasodilators acetylcholine, ATP, or arachidonic acid produces a preferential increase in subendocardial blood flow in anesthetized dogs. This study was performed to assess the effects of coronary artery occlusion and reperfusion on the distribution of myocardial blood flow produced by endothelium-dependent and endothelium-independent vasodilators. The endothelium was damaged by occlusion of the left anterior descending coronary artery for 45 minutes followed by 60 minutes of reperfusion in pentobarbital-anesthetized dogs. Intracoronary infusions of the endothelium-dependent vasodilators acetylcholine, bradykinin, and thiazolylethylamine or the endothelium-independent vasodilator sodium nitroprusside were performed, and regional myocardial blood flow (by radioactive microspheres) was measured before and after occlusion and reperfusion. There were no changes in systemic hemodynamics during intracoronary infusion of vasodilators before or after coronary occlusion and reperfusion. All vasodilators produced similar increases in transmural blood flow before occlusion; however, only the endothelium-dependent vasodilators produced a significant increase in the subendocardial-to-subepicardial blood flow ratio. Increases in transmural flow as well as the preferential increase in subendocardial blood flow produced by acetylcholine, bradykinin, and thiazolylethylamine were attenuated after coronary occlusion and reperfusion. In contrast, increases in transmural blood flow produced by sodium nitroprusside were unchanged. These results suggest that the preferential increase in subendocardial perfusion produced by acetylcholine, bradykinin, and thiazolylethylamine is endothelium-dependent and may be selectively modified by ischemic insult. (Circulation 1990;81:1928-1937 Since the original description by Furchgott and k Zawadzkil of the obligatory role of endothelial cells in vascular relaxation induced by acetylcholine, many other compounds have been shown to be dependent on an intact endothelium for vasoactivity.23 The endothelium has been demonstrated to produce potent vasodilator and vasoconstrictor substances. One of the most potent vasodilator substances is endothelium-derived relaxing factor (EDRF), which may be related to nitric oxide. 45 We have previously demonstrated that intracoronary infusion of the endothelium-dependent vasodilators acetylcholine, ATP, and arachidonic acid produces a preferential increase in subendocardial perfusion, resulting in an increase in the subendocardialto-subepicardial blood flow ratio.6 These compounds stimulate the production and release of EDRF by different mechanisms, including specific receptor stimulation for acetylcholine and ATP or changes in membrane fluidity by arachidonic acid.27 In contrast, infusion of the endothelium-independent vasodilators sodium nitroprusside or nifedipine produces uniform increases in blood flow across the left ventricular wall.6.8 Pharmacological blockade of EDRF by the phospholipase A2 inhibitor quinacrine antagonized the selective redistribution of myocardial blood flow to the subendocardium. Thus, we postulated that the increase in the blood flow ratio was due to the action of EDRF(s).6,8
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Although the results of these previous studies have suggested impaired endothelial-dependent responses after coronary occlusion and reperfusion, no in vivo studies have tested the hypothesis that changes in transmural blood flow distribution occur in response to endothelial-dependent vasodilators subsequent to ischemia and reperfusion injury. Therefore, the present study was undertaken using a modification of a model that produces damage of the myocardial vascular endothelium in vivo in order to characterize the effect this damage has on endothelium-dependent distribution of myocardial blood flow in anesthetized dogs after administration of endothelial-dependent and endothelial-independent vasodilators.
Methods

General Preparation
Adult mongrel dogs of either sex, weighing 15-25 kg, were fasted overnight, anesthetized with sodium pentobarbital (25 mg/kg) and sodium barbital (200 mg/kg), and ventilated by a respirator (model 607, Harvard Apparatus, South Natick, Massachusetts) with room air enriched with oxygen (0.5 to 1.0 1/min). Atelectasis was prevented by maintaining an expiratory pressure of 5-7 cm water with a trap. Respiratory rate and tidal volume were adjusted to maintain arterial blood gases within normal physiological limits (pH, 7.35-7.45; Pco2, 30-35 mm Hg; and Po2, 85-100 mm Hg). Rectal temperature was monitored and maintained at 37.5 ± 10 C by a heating pad and servomechanical controller.
Left ventricular and arterial systolic and enddiastolic pressures were recorded using a 7F dualpressure transducer-tipped catheter (SPR-277, Millar, Houston, Texas) passed through the left carotid artery into the left ventricle and ascending aorta, respectively. The right femoral vein and left femoral artery were catheterized for drug administration and for withdrawal of reference arterial blood samples used in determining myocardial tissue blood flow, respectively. Peak positive dP/dt, an index of left ventricular global contractility, was obtained by electronic differentiation of the left ventricular pressure pulse. A triangular wave signal of known slope was used to calibrate the differentiator. Thoracotomy was performed at the left fifth intercostal space. The lung was retracted and the heart suspended in a pericardial cradle. A distal segment of a small-diameter diagonal branch of the left anterior descending coronary artery was dissected from sur-rounding tissue and cannulated with a heparin-filled catheter (Millar-PE60) for intracoronary drug infusions. The site of the catheter placement was chosen to perfuse approximately equal regions of the left ventricle in all groups. The percent of left ventricle perfused by drug was between 29% and 32% in the four groups. The tip of the catheter was advanced to the origin of the branch of the left anterior descending artery to minimize trauma to the endothelium of the main coronary artery. A 1.0-1.5-cm segment of the left anterior descending coronary artery was carefully dissected from surrounding tissue distal to the cannulated branch, and an electromagnetic flow probe (Statham 7515, Gould Instruments, Cleveland, Ohio) was placed around the vessel for measurement of coronary blood flow. A micrometer-driven mechanical occluder12 positioned immediately distal to the flow probe was used to briefly occlude the vessel to elicit the reactive hyperemic response and to establish zero flow. The flow probe was calibrated with blood at the completion of each experiment. Preparations were not acceptable unless at least a doubling of flow occurred during the reactive hyperemic response to a 20-second total coronary artery occlusion.
Myocardial segment function (percent segment shortening [%SS]) was measured in the regions perfused by the left anterior descending and left circumflex coronary arteries by pairs of piezoelectric crystals. The crystals were inserted (10-15 mm apart and 7-9 mm deep) into the center of the drug-perfused (left anterior descending) and normal (left circumflex) regions parallel to fiber orientation. The leads were connected to an ultrasonic amplifier that transformed the sound pulse transmitted between the two crystals into an electrical signal proportional to the distance between the crystals. The crystals were precalibrated, and the tracings were monitored with an oscilloscope (520, Soltec, San Fernando, California). By recording changes in transmission time, the distance between the two crystals was measured. Using left ventricular dP/dt, end-systolic length (SL) was determined at maximal negative dP/dt, and enddiastolic length (DL) was determined just before the onset of systole. %SS was calculated with the equation: %SS = (DL-SL)/DLx 100. At the completion of each experiment, the depth of each crystal was verified.
A catheter was placed in the left atrium via the atrial appendage for the injection of radioactive microspheres. Heart rate was determined from the electrocardiogram (limb lead II). The electrocardiogram, phasic and mean aortic and left ventricular systolic and end-diastolic pressures, peak positive dP/dt, phasic and mean coronary blood flows, and regional segment function were continuously recorded on a polygraph (model 7, Grass Instrument Co., Quincy, Massachusetts).
The peak reactive hyperemic response to a 20second total coronary artery occlusion was assessed by measuring the mean coronary blood flow at resting and peak levels. Coronary blood flow debt and debt repayment were measured by planimetry. Debt was the area below the curve defined by resting mean coronary flow and the duration of occlusion. Total debt repayment was equal to the area below the mean blood flow tracing from the onset of reperfusion until flow returned to baseline. Percent debt repayment was equal to total debt repayment divided by debt times 100.
The drug-perfused, previously ischemic region of the left ventricle was identified by injection of Patent Blue dye into the left atrium at the completion of each experiment. Saline was simultaneously injected into the left anterior descending coronary artery at the same pressure. In this manner, the ischemic and reperfused area remained unstained, and the normal myocardium was stained dark blue. The heart was then electrically fibrillated, immediately removed, and sliced transversely from apex to base in sections approximately 1 cm in width. The nonstained area was separated from the blue-stained normal area, and the heart slices were fixed in 10% formaldehyde for 24-48 hours. Each tissue sample was subdivided into subepicardial, midmyocardial, and subendocardial layers of approximately equal weight (0.5-1.0 g). The samples were weighed and placed in glass scintillation vials, and the activity of each isotope was determined in duplicate at four energy windows in an Autogamma spectrometer equipped with a dualchannel analyzer (1195, Searle Analytic, Chicago, Illinois). Similarly, the activity of each isotope in the reference blood flow samples was also determined. The true activity of each isotope in the tissue sample was calculated by correcting for energy overlap. Myocardial blood flow (Qm; ml/min/g) was calculated from the equation:
Qm Qr Cm/Cr where Qr is the rate of withdrawal (ml/min) of the reference blood sample, Cr is the true activity (counts/ min) of the reference blood sample, and Cm is the true activity (counts/min/g) of the myocardial tissue sample. Myocardial blood flow values of tissue samples from the drug-perfused and normal areas were pooled for calculation of flow in the subepicardium, midmyocardium, and subendocardium of each region. Transmural myocardial blood flow was the weighted average of flows in the subepicardium, midmyocardium, and subendocardium in drug-perfused or normal zones.
Experimental Design
After surgery was completed, sotalol (2.0 mg/kg i.v.) was administered to block myocardial and coronary vascular /8-adrenoceptors as previously described.'3 After a 30-minute equilibration period, the peak reactive hyperemic response was obtained after a 20-second total left anterior descending coronary artery occlusion. In 29 dogs, mean coronary blood flow during reactive hyperemia was increased from 23+2 to 93±8 ml/min. This information allowed selection of intracoronary drug doses that produced submaximal vasodilation of the left anterior descending perfusion territory to avoid nonspecific changes in the transmural distribution of coronary flow that occur during maximal vasodilation.14 In addition, intracoronary drug infusion permitted study of the direct effects of the vasodilators on myocardial blood flow independent of peripheral hemodynamic actions.
The endothelium-dependent vasodilators selected for study included acetylcholine (5, 10, and 20 .g/min), bradykinin (3, 6, and 12 ,cg/min), and thiazolylethylamine (52, 105, and 210 gag/min), a selective histamine H1 receptor agonist. The endothelium-independent vasodilator sodium nitroprusside (20, 40 , and 80 gg/ min) was studied for comparison. Separate groups of dogs (n=7-8) were used to study each vasodilator. In all experiments, the first radioactive microsphere was administered during intracoronary infusion of vehicle (control state). Five-minute intracoronary infusions of each vasodilator were then administered in increasing doses to establish dose-response relationships for increases in coronary blood flow. Subsequently, the second microsphere was administered at steady-state flow conditions during a 5-minute intracoronary infusion of a dose of each vasodilator that produced an increase in coronary blood flow that was approximately 50% of the peak reactive hyperemic response.
A 45-minute total left anterior descending coronary artery occlusion was then produced by closure of the vascular occluder. Regional segment function was assessed at several times during occlusion to document passive systolic lengthening as an indicator of the severity of ischemia. Animals that displayed active shortening during occlusion were excluded from the study. After 45 minutes, lidocaine (50 mg i.v.) was administered, and reperfusion was accomplished by release of the vascular occluder. After 60 minutes of reperfusion, the reactive hyperemic response to a 20-second total coronary artery occlusion was measured. The third injection of radioactive microspheres was then made to assess any direct effects of occlusion and reperfusion on resting myocardial perfusion. Each vasodilator was again infused by the intracoronary route in the doses established before occlusion and reperfusion. The fourth radioactive microsphere was injected at steady-state flow conditions during infusion of the vasodilator at the same dose used when the second microsphere was injected.
All drugs were dissolved in 0.9% saline and freshly prepared on the day of the experiment, with the exception of bradykinin, which was prepared as a stock solution and frozen in aliquots.
Statistical Analysis
All values are reported as mean+SEM. Analysis of variance with a randomized complete block design with four treatments was used to test for main effects.'1 Simple effects and differences among experimental groups were examined with the Bonferroni multiple comparisons procedure. Changes in regional flow before and after occlusion and reperfusion were compared with the paired t test. Probability values of less than 0.05 were considered statistically significant.
Results
Hemodynamics
Hemodynamic data after intracoronary infusion of acetylcholine (10 ,ttg/min), bradykinin (6 ,ug/min), thiazolylethylamine (105 ,ug/min), and sodium nitroprusside (40 jug/min) are summarized in Tables 1-4 , respectively. None of the vasodilators produced significant changes in heart rate, left ventricular and aortic pressures, peak positive dP/dt, or regional segment shortening in the drug-perfused or normal regions. In contrast, all four vasodilators produced significant increases in total coronary blood flow of the drug-perfused region that were equal to 46-68% of the peak reactive hyperemic response. Peak diastolic and mean coronary blood flows were increased by all vasodilators, but systolic coronary blood flow was increased in only acetylcholine-and sodium nitroprusside-treated dogs before occlusion and reperfusion. Forty-five minutes of total coronary artery occlusion followed by 60 minutes of reperfusion had no effect on heart rate, left ventricular and aortic pressures, or resting coronary blood flow. The lack of significant systemic and coronary hemodynamic change within and across groups provided evidence of the relative stability of the experimental preparation (Tables 1-4 ). The increase in mean coronary blood flow produced by all doses of acetylcholine, thiazolylethylamine, and bradykinin was attenuated after occlusion and reperfusion. In contrast, the increase in coronary blood flow produced by sodium nitroprusside was unchanged.
Peak positive dP/dt was decreased in all groups after occlusion and reperfusion but significantly so only in the acetylcholineand sodium nitroprussidetreated dogs. Regional segment function in the normal, non-drug-perfused region was unchanged by occlusion and reperfusion. Segment function in the postischemic, drug-perfused region was decreased in all experiments but was not significantly different among groups secondary to experimental variability.
The peak reactive hyperemic response to a 20second total occlusion was also decreased after occlusion and reperfusion in all groups. In 29 dogs, mean coronary blood flow at the peak of reactive hyperemia increased from 23±2 to 98+8 ml/min (an increase of 405%) before and from 20±2 to 62±6 ml/min (an increase of 310%) (p<0.05) after occlusion and reperfusion. In addition, although the total blood flow debt incurred during a 20-second total coronary artery occlusion was unchanged after occlusion and reperfusion (32+3 cm2 before and 28±3 cm2 after), the area below the reactive hyperemic response curve representing total repayment (228±29 cm2 before and 130±18 cm2 after) and percent debt repayment (771±80% before and 483+±61% after) were both significantly decreased after occlusion and reperfusion. Thus, the reactive hyperemic response was attenuated after occlusion and reperfusion; however, significant vasodilator reserve remained in all experiments.
Regional Myocardial Perfusion
Regional myocardial blood flow data in the normal (left circumflex) and drug-perfused ischemic (left anterior descending artery) regions are summarized in Tables 5-8 . There was considerable variation in resting myocardial perfusion among experimental groups, with a statistically significant difference among the acetylcholine-treated group and the bradykinin-, thiazolylethylamine-, or sodium nitroprusside-treated groups. Infusions of vasodilator agents did not change blood flow to the subepicardium, midmyocardium, and subendocardium; transmural flow; or subendocardial-to-subepicardial perfusion ratio of the normal region. Vasodilator   TABLE 4 . Effects of Sodium Nitroprusside (40 Lg/min) Reperfusion infusion in the left anterior descending-perfused region produced an approximately twofold increase in transmural myocardial blood flow in all four experimental groups (Figure 1 ). However, there was a preferential increase in blood flow to the subendocardium during intracoronary infusions of acetylcholine, bradykinin, or thiazolylethylamine that resulted in a large increase in the subendocardialto-subepicardial blood flow ratio (Figure 2 ). In contrast, sodium nitroprusside produced a uniform increase in myocardial perfusion across the left ventricular wall.
Occlusion and reperfusion produced no significant changes in subepicardial, midmyocardial, subendocardial, or transmural blood flow in the normal region (Tables 5-8) . Similarly, no change in subendocardial-to-subepicardial blood flow ratio was observed following coronary occlusion and reperfusion in each group of dogs. These data also provide evidence for the stability of the preparation over time. Occlusion and reperfusion produced few changes in myocardial blood in the left anterior descending area. In the treated area, blood flow was lower in the midwall after coronary occlusion and reperfusion in the acetylcholine series (Table 5 ) and in the midmyocardium and subendocardium in the thiazolylethylamine groups ( in transmural blood flow and subendocardialto-subepicardial blood flow ratio produced by acetylcholine, bradykinin, and thiazolylethylamine were attenuated following occlusion and reperfusion (Figure 2) . In contrast, neither the total increase in transmural flow nor the distribution of myocardial blood flow between subepicardium and subendocardium produced by sodium nitroprusside was altered after occlusion and reperfusion. There was no difference between the increase in subepicardial flow in the drug-perfused ischemic region produced by any of the vasodilators before or after occlusion and reperfusion (Figure 3 ). In contrast, the increase in subendocardial perfusion produced by bradykinin, acetylcholine, and thiazolylethylamine before occlusion was significantly attenuated after occlusion and reperfusion (Figure 1 ). The increase in subendocardial perfusion produced by sodium nitroprusside was unchanged by occlusion and reperfusion (Figure 1 ). Thus, there was a selective attenuation of endothelium-dependent increases in subendocardial perfusion after occlusion and reperfusion. This was reflected in a decrease in subendocardial-to-subepicardial blood flow ratio during endothelium-dependent vasodilation after occlusion and reperfusion without change in the ratio during endothelium-independent vasodilation.
Discussion
The purpose of this investigation was to produce damage to the coronary vascular endothelium (without important myocardial damage) in vivo to determine the effects of this damage on the regional distribution of coronary blood flow produced by endothelium-dependent vasodilators. Occlusion of the left anterior descending coronary artery for 45 minutes followed by 60 minutes of reperfusion selectively attenuated increases in subendocardial flow produced by infusion of endothelium-dependent vasodilators. Thus, endothelium-dependent vasodilators produce an increase in the subendocardialto-subepicardial blood flow ratio, which was dramatically attenuated after occlusion and reperfusion. In contrast, sodium nitroprusside, an endotheliumindependent vasodilator, produced uniform transmural increase in myocardial blood flow of equal magnitude before and after occlusion and reperfusion. Resting coronary blood flow was unchanged after occlusion and reperfusion in all of the experimental groups; however, the reactive hyperemic response to a 20-second total coronary occlusion was decreased after occlusion and reperfusion in all groups.
The endothelium-dependent vasodilators used in this study included acetylcholine, bradykinin, and thiazolylethylamine. All three compounds stimulate EDRF(s) as the result of specific receptor interactions. Previous results from our laboratory demonstrated that the preferential increase in subendocardial blood flow produced by acetylcholine was due to M1 receptor stimulation. 16 Van de Voorde and Leusen17 have shown that the histamine HI receptor was responsible for the release of EDRF in isolated rat aorta. Subsequently, Christensen et al18 demonstrated a preferential increase in the subendocardial-to-subepicardial flow ratio by the histamine H1 receptor agonist, thiazolylethylamine. In several experiments, we have observed that the increase in coronary blood flow produced by intracoronary 19 We have previously demonstrated that several endothelium-dependent vasodilators that act by a variety of mechanisms to stimulate the release of EDRF(s) produce a preferential vasodilation of the subendocardial vasculature.6 Inhibition of phospholipase A2 activity by quinacrine prevented the preferential increase in subendocardial perfusion, suggesting that the endothelium-dependent redistribution of ,ug/min) before and after 45 minutes total coronary artery occlusion followed by 60 minutes reperfusion. myocardial blood flow by acetylcholine, ATP, and arachidonic acid was due to a product of arachidonic acid metabolism. 6 We have also shown that gossypol, a potent inhibitor of EDRF in vitro,20 prevented the increase in subendocardial-to-subepicardial blood flow ratio produced by intracoronary infusion of acetylcholine.21 Thus, the preferential increase in subendocardial perfusion was postulated to be produced by the action of EDRF(s). Unfortunately, both gossypol and quinacrine have many physiological actions and cannot be classified as truly specific inhibitors of EDRF. Thus, assessment of a nonpharmacological technique for selective blockade of endothelium-dependent alterations in distribution of myocardial blood flow was a major goal of this study. Endothelial cell denudation or damage of large epicardial coronary arteries in vitro has been accomplished by several methods: perfusion with distilled water,22 saponin,23 high pressure,2425 and electrical stimulation to generate free radicals. 26 Although mechanical removal of endothelium from large coronary vessels may be effective, this procedure cannot be used to examine effects of endothelial cell denudation of the microcirculation. Laser activation of dye has been shown to inhibit endotheliumdependent relaxation in the intact cerebral microcirculation of the mouse. 27 The ultrastructural changes produced with the laser-dye technique were minimal. Results obtained with this methodology failed to support the hypothesis that irreversible cell damage or death caused by the light-dye injury are necessary to cause the loss of endothelium-dependent relaxation. 28 In a later study, Rosenblum29 showed that the loss of endothelium-dependent relaxation was reversible. This technique is not readily applicable to the myocardial microcirculation; however, the ultrastructural data obtained suggest that only endothelial damage and not denudation is necessary to inhibit endothelium-dependent responses in vivo. Several studies have demonstrated the reduction of endothelium-dependent responses in large epicardial vessels placed in tissue baths after removal from hearts subjected to coronary occlusion and reperfusion.8-10 In a recent study, Mehta et all' used a 60-minute occlusion followed by reperfusion for another 60 minutes to examine the coronary vasodilator response to acetylcholine and bradykinin. These investigators demonstrated loss of coronary vasodilator reserve and attenuation of acetylcholineand bradykinin-induced increases in coronary blood flow after occlusion and reperfusion. Nichols et a130 demonstrated a similar decrement in the response to acetylcholine after 1 hour of occlusion and 1 hour of reperfusion. In addition, coronary vasodilator reserve as assessed by a reduction in peak reactive hyperemic response was blunted in this study. 30 Mehta et al have recently demonstrated that the vasodilator responses to acetylcholine and nitroglycerin were equally impaired after 60 minutes of occlusion and reperfusion.31 Superoxide dismutase modified the impairment of coronary vasodilator reserve and reduced myocardial neutrophil accumulation and neutrophil plugging produced by occlusion and reperfusion in intact dogs. These authors suggested that the loss of vasodilator reserve could be related to the loss of EDRF as well as to neutrophil plugging. The results of the present investigation demonstrate that the reactive hyperemic response in all groups was diminished after 45 minutes of occlusion and 60 minutes of reperfusion. In contrast to the study by Mehta, the vasodilator response to the endotheliumindependent compound sodium nitroprusside was unchanged in the present study. Thus, the shorter occlusion period used in the present investigation may produce a more selective effect on endotheliumdependent vasodilation. However, more research, including careful histopathological studies or other measures of endothelial injury, is required to document the selectivity of shorter periods of occlusion for injury to vascular endothelium. Distribution of resting coronary blood flow was unchanged after occlusion and reperfusion in all groups in the present study. However, the distribution of blood flow produced by the endothelium-dependent vasodilators was altered after occlusion and reperfusion, whereas that produced by sodium nitroprusside was unchanged. We did not document neutrophil plugging in these experiments; however, reduced microvascular cross-sectional area should have affected the distribution of blood flow to an equal extent in all groups. Similarly, other possible mechanisms for attenuation of vasodilator-induced increases of subendocardial flow, including increased extravascular compressive forces secondary to edema and reduced regional oxygen consumption, should have had similar effects on endothelium-dependent and endothelium-independent vasodilation. Thus, the present results support the hypothesis that 45 minutes of occlusion followed by 60 minutes of reperfusion produced functional damage to vascular intima, which prevented a preferential increase in subendocardial blood flow by endothelium-dependent vasodilators.
